Table 3. Sensitivity analysis of IPIs among HIV/AIDS patients in Ethiopia.
Studies omitted | Prevalence(%) with 95% CI |
---|---|
Adamu et al [42] | 36.49 (35.31, 37.68) |
Alemu et al [41] | 37.17 (35.98, 38.63) |
Alemu et al [4] | 34.90 (33.71, 36.09) |
Gedle et al [40] | 36.87 (35.67, 38.07) |
Missaye et al [43] | 37.25 (36.05, 38.45) |
Kiros et al [18] | 37.27 (36.06, 38.48) |
Eshetu et al [17] | 37.13 (35.94, 38.32) |
Teklemariam et al [19] | 37.02 (35.81, 38.22) |
Shimelis et al [29] | 36.09 (35.69, 38.12) |
Fekadu et al [5] | 36.26 (35.06, 37.46) |
Adamu et al [44] | 35.31 (34.10, 36.51) |
Zeynudin et al [28] | 36.78 (35.61, 37.96) |
T.Mariam et al [38] | 36.33 (35.15, 37.51) |
Kindie et al [37] | 36.68 (35.50, 37.86) |
Gebretsadik et al [30] | 38.45 (37.24, 39.66) |
Awol et al [35] | 36.59 (35.41, 37.78) |
Mahmud et al [21] | 35.73 (34.53, 36.93) |
Gebrewahid et al [16] | 37.31 (36.11, 38.50) |
Gebrecherkos et al [32] | 36.63 (35.45, 37.82) |
Alemayehu et al [34] | 37.72 (36.50, 38.93) |
Gietaneh et al [33] | 37.83 (36.61, 39.04) |
Mesfun et al [39] | 37.56 (36.32, 38.75) |
Overall | 39.15 (32.34, 45.95) |